GCN2 regulates BMP signaling: consequence for PVOD pathobiology and therapeutic management
G. Manaud (Le Kremlin-Bicêtressis-Robinson, France), M. Lambert (Le Kremlin-Bicêtressis-Robinson, France), B. Soilih (Le Kremlin-Bicêtresis-Robinson, France), B. Girerd (Le Kremlin-Bicêtre, France), F. Soubrier (Paris, France), J. Bignard (Paris, France), O. Claude (Paris, France), F. Lecerf (Le Kremlin Bicêtre, France), M. Florio (Thousand Oaks, United States of America), B. Sun (Thousand Oaks, United States of America), S. Nadaud (Paris, France), S. Verleden (Leuven, Belgium), S. Rémy (Nantes, France), I. Anegon (Nantes, France), O. Mercier (Le Plessis-Robinson, France), E. Fadel (Le Plessis-Robinson, France), G. Simmoneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), F. Antigny (Le Kremlin-Bicêtre, France), F. Perros (Le Kremlin-Bicêtre, France)
Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension
Session: Pathophysiology of pulmonary hypertension
Session type: E-poster session
Number: 3551
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Manaud (Le Kremlin-Bicêtressis-Robinson, France), M. Lambert (Le Kremlin-Bicêtressis-Robinson, France), B. Soilih (Le Kremlin-Bicêtresis-Robinson, France), B. Girerd (Le Kremlin-Bicêtre, France), F. Soubrier (Paris, France), J. Bignard (Paris, France), O. Claude (Paris, France), F. Lecerf (Le Kremlin Bicêtre, France), M. Florio (Thousand Oaks, United States of America), B. Sun (Thousand Oaks, United States of America), S. Nadaud (Paris, France), S. Verleden (Leuven, Belgium), S. Rémy (Nantes, France), I. Anegon (Nantes, France), O. Mercier (Le Plessis-Robinson, France), E. Fadel (Le Plessis-Robinson, France), G. Simmoneau (Le Kremlin-Bicêtre, France), M. Humbert (Le Kremlin-Bicêtre, France), D. Montani (Le Kremlin-Bicêtre, France), F. Antigny (Le Kremlin-Bicêtre, France), F. Perros (Le Kremlin-Bicêtre, France). GCN2 regulates BMP signaling: consequence for PVOD pathobiology and therapeutic management. 3551
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: